China Medical System Holdings Limited (CHSYF)

Market Cap	4.03B
Revenue (ttm)	1.02B
Net Income (ttm)	221.92M
Shares Out	n/a
EPS (ttm)	0.09
PE Ratio	18.14
Forward PE	17.45
Dividend	n/a
Ex-Dividend Date	n/a

Volume	110
Average Volume	1,841
Open	0.9307
Previous Close	0.9307
Day's Range	0.9307 - 0.9307
52-Week Range	0.9307 - 1.5180
Beta	1.00
RSI	36.95
Earnings Date	Aug 18, 2025

About CHSYF

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 6,141
• Stock Exchange: OTCMKTS
• Ticker Symbol: CHSYF

Financial Performance

In 2024, CHSYF's revenue was 7.47 billion, a decrease of -6.79% compared to the previous year's 8.01 billion. Earnings were 1.62 billion, a decrease of -32.54%.

Financial numbers in CNY